Jacobs Levy Equity Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Jacobs Levy Equity Management’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-296,312	Closed	-$824K	–	1107
2023 Q1	$824K	Sell	296,312 -47,036	-14%	-$134K	0.01%	737
2022 Q4	$1.18M	Sell	343,348 -812,916	-70%	-$2.32M	0.01%	656
2022 Q3	$2.97M	Buy	1,156,264 +917,090	+383%	+$2.92M	0.02%	484
2022 Q2	$579K	Buy	239,174 +68,551	+40%	+$180K	﹤0.01%	851
2022 Q1	$703K	Buy	170,623 +80,818	+90%	+$428K	﹤0.01%	812
2021 Q4	$1.16M	Hold	89,805	–	–	0.01%	718
2021 Q3	$970K	Sell	89,805 -1,086	-1%	-$9.88K	0.01%	751
2021 Q2	$830K	Buy	90,891 +1,086	+1%	+$10K	0.01%	779
2021 Q1	$847K	Sell	89,805 -59,760	-40%	-$823K	0.01%	778
2020 Q4	$589K	Sell	149,565 -8,295	-5%	-$25.1K	0.01%	829
2020 Q3	$418K	Buy	157,860 +135,847	+617%	+$504K	﹤0.01%	838
2020 Q2	$146K	Buy	+22,013	New	+$148K	﹤0.01%	986

Other funds holding GRTS

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management's GRTS Position: Q2 2023 in Review

Jacobs Levy Equity Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2023, closing a stake of 296,312 shares — an estimated $824K sold.

Jacobs Levy Equity Management first reported a position in GRTS in Q2 2020 and held it in 12 quarters. The position peaked at $2.97M in Q3 2022. 88 funds tracked by Wall St. Rank hold GRTS as of Q2 2023.

Jacobs Levy Equity Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Jacobs Levy Equity Management sold 296,312 Gritstone bio, Inc. Common Stock shares in Q2 2023, an estimated $824K.
Jacobs Levy Equity Management first reported a position in Gritstone bio, Inc. Common Stock in Q2 2020 and held it in 12 quarters.
Jacobs Levy Equity Management's Gritstone bio, Inc. Common Stock position peaked at $2.97M in Q3 2022.
88 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2023.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2023, filed 14 Aug 2023.